[1]VanDerPoorten,Olivier;VanDenHauwe,Robin;Eiselt,Emilie;Betti,Cecilia;Guillemyn,Karel;Chung,NgaN.;Hallé,François;Bihel,Frédéric;Schiller,PeterW.;Tourwé,Dirk;Sarret,Philippe;Gendron,Louis;Ballet,Steven[ACSMedicinalChemistryLetters,2017,vol.8,#11,p.1177-1182]
[1]VanDerPoorten,Olivier;VanDenHauwe,Robin;Eiselt,Emilie;Betti,Cecilia;Guillemyn,Karel;Chung,NgaN.;Hallé,François;Bihel,Frédéric;Schiller,PeterW.;Tourwé,Dirk;Sarret,Philippe;Gendron,Louis;Ballet,Steven[ACSMedicinalChemistryLetters,2017,vol.8,#11,p.1177-1182]
[1]VanDerPoorten,Olivier;VanDenHauwe,Robin;Eiselt,Emilie;Betti,Cecilia;Guillemyn,Karel;Chung,NgaN.;Hallé,François;Bihel,Frédéric;Schiller,PeterW.;Tourwé,Dirk;Sarret,Philippe;Gendron,Louis;Ballet,Steven[ACSMedicinalChemistryLetters,2017,vol.8,#11,p.1177-1182]
[1]VanDerPoorten,Olivier;VanDenHauwe,Robin;Eiselt,Emilie;Betti,Cecilia;Guillemyn,Karel;Chung,NgaN.;Hallé,François;Bihel,Frédéric;Schiller,PeterW.;Tourwé,Dirk;Sarret,Philippe;Gendron,Louis;Ballet,Steven[ACSMedicinalChemistryLetters,2017,vol.8,#11,p.1177-1182]
[1]VanDerPoorten,Olivier;VanDenHauwe,Robin;Eiselt,Emilie;Betti,Cecilia;Guillemyn,Karel;Chung,NgaN.;Hallé,François;Bihel,Frédéric;Schiller,PeterW.;Tourwé,Dirk;Sarret,Philippe;Gendron,Louis;Ballet,Steven[ACSMedicinalChemistryLetters,2017,vol.8,#11,p.1177-1182]
Title: Prospective study of p-[123I]iodo-L-phenylalanine and SPECT for the evaluation of newly diagnosed cerebral lesions: specific confirmation of glioma.
Journal: European journal of nuclear medicine and molecular imaging 20101201
Title: 99mTc-tetrofosmin SPECT for the evaluation of cerebral lesions.
Journal: European journal of nuclear medicine and molecular imaging 20101201
Title: Preliminary in vivo evaluation of [131I]-2-iodo-D-phenylalanine as a potential radionuclide therapeutic agent in R1M-fluc rhabdomyosarcoma tumor-bearing NuNu mice using bioluminescent imaging.
Journal: Cancer biotherapy & radiopharmaceuticals 20100401
Title: PET imaging with p-[I-124]iodo-l-phenylalanine as a new tool for diagnosis and postoperative control in patients with glioma.
Journal: Clinical nuclear medicine 20080601
Title: The use of [123I]-2-iodo-L-phenylalanine as an early radiotherapy evaluation tool: in vitro R1M rabdomyosarcoma cell and in vivo mouse experiments.
Journal: Cancer biotherapy & radiopharmaceuticals 20080401
Title: Intra-individual comparison of the human biodistribution and dosimetry of the D and L isomers of 2-[123I]iodo-phenylalanine.
Journal: Nuclear medicine communications 20071001
Title: Optimization by experimental design of precursor synthesis and radiolabeling of 2-iodo-L-phenylalanine, a novel amino acid for tumor imaging.
Journal: Cancer biotherapy & radiopharmaceuticals 20060601
Title: Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine.
Journal: Nuclear medicine and biology 20060101
Title: Influence of sedation and data acquisition method on tracer uptake in animal models: [123I]-2-iodo-L-phenylalanine in pentobarbital-sedated tumor-bearing athymic mice.
Journal: Nuclear medicine and biology 20060101
Title: In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20051201
Title: In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20050301
Title: Synthesis, radiosynthesis, and in vitro characterization of [125I]-2- iodo-L-phenylalanine in a R1M rhabdomyosarcoma cell model as a new potential tumor tracer for SPECT.
Journal: Nuclear medicine and biology 20040801
